Literature DB >> 8648737

Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.

S R Himes1, R Katsikeros, M F Shannon.   

Abstract

Many cell signals such as CD28 and CD4 binding can costimulate cytokine gene expression in activated T cells. We have found that the human T leukemia/lymphotropic virus type 1 viral protein Tax can also strongly costimulate expression of interleukin-2 (IL-2), IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA in T cells activated with the phorbol ester phorbol myristate acetate (PMA) and calcium ionophore, which can mimic activation through the antigen specific T-cell receptor. Reporter constructs also showed strong synergy between both stimuli and showed that Tax and the PMA-Ca2+ ionophore act through different regions of the IL-2 and GM-CSF genes. Furthermore, the Tax-responsive regions (TxRR) from both GM-CSF and IL-2 respond to costimulation through the CD28 surface receptor. The GM-CSF and IL-2 TxRRs showed significantly higher levels of NF-kappaB/rel binding, following induction by Tax, compared with that of the PMA-Ca2+ ionophore with only Tax capable of inducing c-Rel binding to a Consensus kappaB element within the GM-CSF TxRR. Tax protein mutants, however, showed that a pathway(s) other than NF-kappaB/rel induction could also cooperate with the PMA-Ca2+ ionophore to activate the GM-CSF and IL-2 genes. This high-level costimulation by Tax, through multiple pathways, may be important in the early stages of leukemia and in the nervous system disorder tropical spastic paraparesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648737      PMCID: PMC190278     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth.

Authors:  Y Wano; M Feinberg; J B Hosking; H Bogerd; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  The role of the antigen receptor/T3 complex in T-cell activation.

Authors:  A Weiss; J Imboden; K Hardy; J Stobo
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

3.  Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.

Authors:  M Siekevitz; M B Feinberg; N Holbrook; F Wong-Staal; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

5.  Activation of T cell-derived lymphokine genes in T cells and fibroblasts: effects of human T cell leukemia virus type I p40x protein and bovine papilloma virus encoded E2 protein.

Authors:  S Miyatake; M Seiki; R D Malefijt; T Heike; J Fujisawa; Y Takebe; J Nishida; J Shlomai; T Yokota; M Yoshida
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

6.  HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.

Authors:  D W Ballard; E Böhnlein; J W Lowenthal; Y Wano; B R Franza; W C Greene
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

7.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

Review 8.  GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells.

Authors:  M F Shannon; S R Himes; L S Coles
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Nuclear proteins interacting with the promoter region of the human granulocyte/macrophage colony-stimulating factor gene.

Authors:  M F Shannon; J R Gamble; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more
  6 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Constitutive expression of the HTLV-I pX and env regions in Jurkat T-cells induces differential activation of SRE, CRE and NF kappa B pathways.

Authors:  A C Black; J Luo; S Chun; S Tabibzadeh
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.

Authors:  M Kochetkova; P O Iversen; A F Lopez; M F Shannon
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission.

Authors:  M Moriuchi; H Inoue; H Moriuchi
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

6.  Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins.

Authors:  Adele F Holloway; Sudha Rao; Xinxin Chen; M Frances Shannon
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.